Can we treat patients with underlying autoimmune disease or paraneoplastic syndrome with immune checkpoint inhibition?
Generally patients with underlying autoimmune disease (AID) or autoimmune paraneosplastic syndrome (PNS) have mostly been excluded from phase III trials …